PQQ Dosage, half-life & reference guide
Also known as Pyrroloquinoline quinone · PQQ disodium salt · Methoxatin
Reviewed Evidence: EmergingPublished by PepVault
A small molecule found in some foods that supports mitochondria in animal studies. In people, a short study saw inflammation markers fall, and two Japanese trials of about 20 mg a day reported better memory and attention over 12 weeks. The trials are small and mostly test one company's ingredient.
- Studied range
- 20–21.5 mg
- How often
- Daily
- Evidence
- ●
●●Emerging - Route
- Oral capsule
Studied in research — not a recommendation.
How it works.
PQQ is a small redox molecule found in foods, and in animal studies it supports mitochondrial function. In a small human study, a few days of PQQ lowered inflammation markers (CRP, IL-6) and shifted urine metabolites in a way consistent with more mitochondrial activity. Two 12-week Japanese trials of about 20 mg a day reported better memory and attention against placebo. The trials are small and mostly test one maker's ingredient.
Commonly reported: Subtle focus gains for some.
Your report
Taken PQQ? What did you notice?
One tap to start. About 30 seconds, no account.

Week by week.
What to expect in the first 8 weeks
- Onset
- 8–12 weeks (cognition, in trials)
- Peak effect
- 12 weeks
- Duration
- Ongoing; trials ran 12 weeks
Day 1–7Clinical
Inflammation markers dip quickly
In a small crossover study, three days of PQQ lowered the inflammation markers CRP and IL-6, and urine metabolites shifted in a way that suggests more mitochondrial activity. Ten people is a starting point, not proof.
The science
Harris 2013 (J Nutr Biochem): 10 adults; single 0.2 mg/kg dose, then 0.3 mg/kg daily for 76 h; clinical indices normal and unchanged; plasma CRP and IL-6 and urinary methylated amines (incl. TMAO) decreased; urinary NMR metabolites consistent with enhanced mitochondria-related functions.
Sources- Harris et al. (2013)
Updated Nov 2026
Day 7–42RCT
In mild memory problems, a mixture trial
A six-week trial in older adults with mild cognitive impairment gave PQQ mixed with hydrogen-producing minerals, so it cannot isolate PQQ. It is one more small piece of the picture.
The science
Baltic 2024 (J Nutr Health Aging): 34 older adults (mean age 72) with MCI, a dihydrogen-producing mineral and PQQ mixture or placebo twice daily for 6 weeks; primary end point serum BDNF.
Sources- Baltic et al. (2024)
Updated Nov 2026
Day 28–84RCT
Memory and attention in 12-week trials
Two placebo-controlled Japanese trials of about 20 mg a day found better memory and attention after 12 weeks, in older and younger adults. Commonly reported: slightly sharper focus.
The science
Shiojima 2022 (J Am Nutr Assoc): 64 adults aged 40 to under 80 (58 completed), PQQ disodium salt 21.5 mg a day or placebo for 12 weeks; composite memory, verbal memory, reaction time, complex attention, cognitive flexibility, executive function and motor speed improved vs placebo; no adverse events. Tamakoshi 2023 (Food Funct): adults 20–65, 20 mg a day; memory improved at 12 weeks, flexibility and speed at 8 weeks in the younger group.
Sources- Shiojima et al. (2022)
- Tamakoshi et al. (2023)
Updated Nov 2026
Any dayRCT
What PQQ is built on
Animal work on mitochondria, one small human mechanistic study, and a few small cognition trials, largely of one branded ingredient. It has not been tested for lifespan in mice or people.
The science
Harris 2013; Shiojima 2022; Tamakoshi 2023; Baltic 2024 tested a dihydrogen + PQQ mixture in 34 older adults with mild cognitive impairment for 6 weeks (BDNF primary outcome). Not tested by the NIA ITP.
Sources- Harris et al. (2013)
- Shiojima et al. (2022)
- Baltic et al. (2024)
Updated Nov 2026
With CoQ10Community
The mitochondria pair
PQQ is often paired with CoQ10 on the idea that one supports mitochondria and the other the energy chain inside them. The pair has not been tested together in people.
The science
PQQ: mitochondrial effects in animals and urinary mitochondrial markers in people (Harris 2013). CoQ10: its library entry. Combination: community practice.
Sources- Harris et al. (2013)
Updated Nov 2026
Day 1 is the day you start it.
A 10-person mechanistic study and small 12-week RCTs, mostly of one company's ingredient.
Preliminary research
A typical run.
Run notes
- Cycle
- Daily for 12 weeks in the cognition trials.Community practice — opinions vary. Not a clinical recommendation.
- Timing
- No trial compared times of day.
- Route
- Oral capsule
- Stacks
- CoQ10, NAD+, Urolithin A
Safety.
Common side effects
- No adverse events in the 12-week trial read
Interactions
No drug interactions were reported in the PQQ trials read. Discuss any prescription medications with your clinician.
Safety notes
PQQ is a dietary supplement. The 12-week cognition trial reported no adverse events, and standard blood tests were unchanged in the short human study. No official upper level is set in EFSA's overview. Discuss with your clinician.
Goes with.
One question at a time.
Questions people ask.
What is PQQ?
A small molecule found in some foods that supports mitochondria in animal studies. In people, a short study saw inflammation markers fall, and two Japanese trials of about 20 mg a day reported better memory and attention over 12 weeks. The trials are small and mostly test one company's ingredient.
How is PQQ dosed in research?
The research range for PQQ is 20–21.5 mg, daily. Studied in research — not a recommendation.
How long does PQQ last?
The half-life of PQQ is not established in the sources read (plasma and urine levels were followed for 48 hours after a single dose, Harris 2013).
What do people report on PQQ?
Commonly reported on PQQ: subtle focus gains for some.
Is PQQ safe?
The research basis for PQQ is emerging: primarily preclinical / limited human data. Common side effects in the library: no adverse events in the 12-week trial read.
What does PQQ stack with?
Common stacks for PQQ: CoQ10, NAD+ and Urolithin A.
Research.
Reference.
- Cadence
Daily
- Half-life
Not established in the sources read (plasma and urine levels were followed for 48 hours after a single dose, Harris 2013)
- Research basis
●
●●EmergingPrimarily preclinical / limited human data
Reviewed How we check the library
